HLA-DR4 antigen and IgM rheumatoid factors

Area of Science:

• Immunogenetics
• Rheumatology
• Human Leukocyte Antigens (HLA)

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints.
• Rheumatoid factors (RF), particularly IgM RF, are common autoantibodies found in RA patients.
• The human major histocompatibility complex (MHC), including HLA genes, plays a crucial role in immune responses.

Purpose of the Study:

• To investigate the association between the HLA-DR4 antigen and the presence of IgM rheumatoid factors (RF) in patients with rheumatoid arthritis.
• To explore potential links between other HLA antigens and autoantibodies in RA.

Main Methods:

• Case-control study comparing 80 rheumatoid arthritis patients with 66 healthy controls.
• Genotyping for 7 HLA-DR antigens and 38 HLA-A, B, C antigens in all participants.
• Statistical analysis to determine the prevalence and significance of antigen associations with RF and antinuclear antibodies.

Main Results:

• The HLA-DR4 antigen was significantly more prevalent in RA patients (48.7%) compared to controls (12.1%) (p < 0.001).
• HLA-DR4 was strongly associated with IgM RF positivity, found in 89.7% of seropositive patients versus 39% of seronegative patients (p < 0.00001).
• A positive association was observed between HLA-DR3 and antinuclear antibodies (p < 0.01).

Conclusions:

• The findings strongly suggest that the HLA-DR4 antigen is a genetic marker associated with the development of IgM rheumatoid factors in rheumatoid arthritis.
• The results support the hypothesis that specific immune response genes within the human MHC influence susceptibility to autoimmune conditions like RA and the production of autoantibodies.